Dry eyes are one of the most common complaints in ophthalmology — and their frequency is growing in the modern working world. Screens, air conditioning, contact lenses and advancing age are the best-known triggers. What many people don't realise: science has gathered increasing evidence in recent years that omega-3 fatty acids — specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) — may play a role in stabilising the tear film and reducing signs of inflammation at the eye surface. A meta-analysis of 17 randomised controlled trials with over 3,000 patients provides impressive figures. This article explains what studies show, how dry eye syndrome develops and what you can practically do.
What is dry eye syndrome (keratoconjunctivitis sicca)?
Dry eye syndrome, medically known as keratoconjunctivitis sicca or sicca syndrome, is a multifactorial disease of the ocular surface. It occurs when the tear film is qualitatively or quantitatively inadequate — leaving the cornea and conjunctiva insufficiently moistened and protected.
According to TFOS DEWS II (Tear Film & Ocular Surface Society Dry Eye WorkShop II), dry eye syndrome affects between 5 and 50 per cent of the population worldwide, depending on the definition and study population. Women are more frequently affected than men, and prevalence increases significantly with age.
The two main forms of dry eye
Two main mechanisms are distinguished:
- Evaporative dry eye (more common, approx. 85%): The tear film evaporates too quickly. The cause is usually meibomian gland dysfunction (MGD) — the lipid layer of the tear film that slows evaporation is disrupted. Screen use, contact lenses and hormonal changes favour this type.
- Aqueous-deficient dry eye (less common, approx. 15%): The lacrimal glands produce too little watery tear fluid. A common cause is Sjögren's syndrome, an autoimmune condition.
In practice, mixed forms are common. Inflammatory reactions at the ocular surface are a key feature of both forms — and this is precisely where omega-3 fatty acids may have a role.
Why screen use increases the risk
When concentrating on screens, blinking frequency drops considerably — from around 15–20 times per minute to 5–7 times per minute. Less blinking means less distribution of tear fluid across the cornea and faster evaporation of the tear film.
Modern office work adds further factors: air conditioning lowers humidity, screens are often positioned slightly below eye level (increasing lid opening and the evaporation surface), and blue light may affect gland function. The result: dry eyes have become a widespread condition among office workers.
Common symptoms of dry eyes
Typical complaints include: burning and stinging, a foreign body sensation ("grit in the eye"), redness, light sensitivity, blurred vision (especially after prolonged reading or screen use), paradoxical tearing (reflex tears in response to irritation) and difficulties wearing contact lenses.
How omega-3 may influence the tear film
EPA and DHA act on dry eye through several pathways that are now well researched:
Anti-inflammatory effects at the ocular surface
Chronic inflammatory reactions at the cornea and conjunctiva are both a cause and a consequence of dry eye — a vicious cycle. Pro-inflammatory cytokines (such as IL-1, IL-6, TNF-alpha) damage goblet cells that produce vital mucins for the tear film. EPA and DHA, as precursors for pro-resolving lipid mediators (resolvins, protectins), can interrupt this cycle. More on the general anti-inflammatory effects of omega-3 can be found in the article Omega-3 and inflammation.
Improvement of meibomian gland function
The meibomian glands produce the lipid layer of the tear film. In meibomian gland dysfunction (MGD), their secretions are altered and promote tear film instability. Omega-3 fatty acids influence the fatty acid composition of meibomian secretions and may improve their quality. Various studies have observed that omega-3 supplementation prolongs tear film break-up time — a direct indicator of a more stable lipid layer.
Modulation of lacrimal gland secretion
Omega-3 fatty acids can influence the secretory function of the lacrimal glands. EPA and DHA act on prostaglandin signalling pathways involved in regulating tear production. Increased production of aqueous tear fluid may be a further mechanism by which omega-3 benefits dry eye.
The key study: Giannaccare et al. 2019
The most comprehensive evaluation to date of omega-3's effects on dry eyes was published in 2019 in the journal Cornea. The meta-analysis by Giannaccare and colleagues pooled 17 randomised controlled trials (RCTs) and represents the strongest available evidence for omega-3's efficacy in this indication.
Dry eye: systematic review of 17 randomised trials with 3,363 patients
This meta-analysis pooled 17 randomised controlled trials with a total of 3,363 patients. Omega-3 supplementation showed significant improvements versus placebo across all four measured parameters:
- Subjective symptoms: SMD = 0.968 (P < 0.001)
- Tear film break-up time (TBUT): SMD = 0.905 (P < 0.001)
- Tear production (Schirmer test): SMD = 0.905 (P < 0.001)
- Corneal fluorescein staining (surface damage): SMD = 0.517 (P = 0.032)
These effect sizes (SMD = Standardised Mean Difference) are notable: an SMD above 0.8 is considered a "large effect" by Cohen's criteria. This means omega-3 showed not only statistically significant but also clinically relevant improvements in this meta-analysis.
What the four measured parameters mean
To contextualise the results, it helps to understand what each parameter measures:
- Subjective symptoms: Patients' self-assessed experience of burning, stinging, foreign body sensation, dryness — usually via standardised questionnaires such as OSDI or SPEED.
- TBUT (Tear Break-Up Time): How long it takes for the tear film to develop gaps after a blink. A short TBUT (under 10 seconds) is considered pathological. Prolongation of TBUT indicates a more stable tear film.
- Schirmer test: Measures the production of aqueous tear fluid: a strip of blotting paper is placed under the lower eyelid and the moistened length measured after 5 minutes. A Schirmer value below 5 mm is considered pathological.
- Corneal fluorescein staining: After the introduction of a dye (fluorescein), damaged cells on the corneal surface become visible. A reduction in staining indicates less surface damage.
The fact that omega-3 significantly improved all four parameters in the meta-analysis supports an effect at multiple levels of the disease process.
Study overview: omega-3 and dry eye
| Parameter | Result (SMD) | Significance | Clinical interpretation |
|---|---|---|---|
| Subjective symptoms (burning, dryness, foreign body) |
SMD = 0.968 | P < 0.001 | Large effect |
| Tear film break-up time (TBUT) |
SMD = 0.905 | P < 0.001 | Large effect |
| Schirmer test (tear production) |
SMD = 0.905 | P < 0.001 | Large effect |
| Corneal fluorescein staining (surface damage) |
SMD = 0.517 | P = 0.032 | Moderate effect |
| Total dataset | 17 RCTs · 3,363 patients · Cornea 2019 · PMID 30702470 | ||
Dosage: how much EPA and DHA for dry eyes?
Dosages used in the reviewed studies varied considerably — from around 400 mg to over 3,000 mg EPA+DHA per day. A uniform "optimal dose" for dry eyes cannot therefore be derived from the meta-analysis.
In practice, dosages in the range of 1,000–2,000 mg EPA+DHA per day, divided into two to three doses, are commonly used for dry eyes. An important consideration is choosing a fresh (non-oxidised) supplement with a balanced EPA-DHA ratio.
Practical tip: omega-3 for dry eyes
Studies show that supplementation should typically continue for at least 3 months before assessing its effect. Short-term use over a few weeks is not sufficient to achieve statistically measurable improvements in most studies. Combine omega-3 with adequate hydration, screen breaks (20-20-20 rule) and, if needed, artificial tears. A detailed dosage overview can be found in the article Omega-3 dosage per day.
Omega-3 compared to other treatment approaches
Dry eye is typically managed with a stepwise approach: first artificial tears, then measures to improve meibomian gland function (warm compresses, lid hygiene), and for severe cases, anti-inflammatory eye drops (cyclosporine A) or other interventions.
Omega-3 is increasingly discussed in ophthalmology as a complementary measure, as it acts systemically — influencing not just the ocular surface but the body's overall inflammatory status. It is not a replacement for artificial tears or medical treatment, but may be a sensible component of a comprehensive management approach.
There is broad evidence for omega-3's systemic anti-inflammatory effects beyond dry eye — an overview can be found in the article Omega-3 and inflammation.
EPA vs. DHA: which fatty acid matters more?
For dry eyes, EPA and DHA appear to act together — most studies used combination supplements. EPA primarily supplies building blocks for pro-resolving eicosanoids (E-series resolvins), while DHA is a precursor for protectins and D-series resolvins. Neuroprotectin D1 (from DHA) has also been detected in tear fluid and protects the ocular surface. A preference for one fatty acid over the other for dry eyes cannot be derived from current research — a balanced EPA+DHA supplement appears most appropriate.
The 20-20-20 rule and other practical measures
Omega-3 is not a cure-all — for lasting improvement, it should be embedded within a holistic approach. The following measures complement omega-3 supplementation effectively:
Screen breaks following the 20-20-20 rule
Every 20 minutes: look at a point at least 20 feet (~6 metres) away for 20 seconds. This relieves eye strain and encourages conscious blinking.
Optimising your working environment
- Use a humidifier if indoor air is dry (optimal: 40–60% relative humidity)
- Position your screen slightly below eye level (so lids partially cover the eyes)
- Avoid draughts from air conditioning and heating vents
- Stay well hydrated
Lid hygiene and heat therapy
A daily warm compress (10 minutes, approx. 40°C) improves meibomian gland secretion. Subsequent lid cleaning with specialist products or diluted baby shampoo can open blocked gland openings. These measures act directly on the lipid layer of the tear film — complementing the systemic action of omega-3.
Important: contact lens wearers
Contact lenses often significantly worsen dry eyes, as they disrupt tear film distribution and restrict oxygen supply to the cornea. If you suffer from dry eyes and wear contact lenses, discuss with your ophthalmologist whether switching to daily lenses, moisture-retaining lenses or temporarily discontinuing lens wear is advisable. Omega-3 can alleviate but not fully compensate for the problem in contact lens wearers.
Are there studies showing no effect?
Scientific honesty requires a critical look at the evidence base. The DREAM study (Dry Eye Assessment and Management), published in 2018 in the New England Journal of Medicine, found no statistically significant difference between omega-3 (3,000 mg/day) and olive oil placebo in 535 patients with moderate to severe dry eye after 12 months on the primary endpoint (OSDI score).
This study appears to contradict the Giannaccare meta-analysis. However, scientists have discussed various methodological particularities of the DREAM study: olive oil is not an inert placebo — it contains anti-inflammatory compounds (oleocanthal) and may itself influence inflammatory parameters. The choice of an active comparator may have obscured real differences.
Overall, the cumulative evidence from 17 RCTs in the Giannaccare meta-analysis is broader and more consistent than any single study. The research landscape remains active, and further high-quality RCTs are needed for a definitive picture.
Omega-3 and AMD: the broader connection to eye health
Beyond dry eye, omega-3 fatty acids are investigated in research for other eye conditions — in particular age-related macular degeneration (AMD). Studies show an association between high omega-3 intake and reduced AMD risk. A detailed article is available here: Omega-3 for the eyes: DHA and normal vision.
Frequently asked questions
How quickly does omega-3 work for dry eyes?
Studies examined treatment periods from 4 weeks to 12 months. Short-term effects after 4–6 weeks are possible, but reliable, clinically measurable improvements appeared in most studies only after 3 months of continuous use. Omega-3 should not be seen as an instant fix — it provides medium- to long-term support.
Can I use omega-3 alongside eye drops?
Yes. Omega-3 works systemically (via the bloodstream), whereas artificial tears act locally on the eye surface. Both approaches complement each other as they address different mechanisms. Omega-3 may help address the underlying cause (inflammation, lipid layer quality), while drops relieve symptoms. The combination is frequently recommended in practice. Speak with your doctor about the optimal combination for your situation.
What dosages were studied for dry eyes?
Dosages in the 17 RCTs of the Giannaccare meta-analysis varied considerably — from around 400 mg to over 3,000 mg EPA+DHA per day. The most commonly studied range was 1,000–2,000 mg EPA+DHA per day. A standardised optimal dose for dry eyes cannot be derived from the current research. Consult your ophthalmologist for individual guidance.
Is algae oil also suitable for dry eyes?
Algae oil contains DHA and increasingly EPA in meaningful amounts, making it a plant-based alternative to fish oil. For dry eyes, EPA is particularly interesting as a precursor for pro-resolving eicosanoids. Most studies in the Giannaccare meta-analysis used fish oil supplements. High-quality algae oils with sufficient EPA (not only DHA) should be comparably effective — however, direct comparison studies are lacking.
Can dry eyes be caused by omega-3 deficiency?
A direct causal link between omega-3 deficiency and the development of dry eyes is not conclusively established. However, studies show that people with dry eyes tend to have lower omega-3 blood levels than healthy controls. Whether this is a cause or consequence cannot be resolved from observational studies. What is clear: adequate omega-3 intake appears beneficial for ocular surface health.
Can I take omega-3 if I have Sjögren's syndrome?
Sjögren's syndrome is an autoimmune condition often associated with severe dry eyes (aqueous-deficient type). Omega-3 may be useful as a complement to immunomodulatory treatment, as it influences the inflammatory profile. This should always be discussed with your rheumatologist and ophthalmologist — particularly if immunosuppressants or corticosteroids are being used.
Medical disclaimer
This article is for general information purposes only and does not replace medical advice. All health statements are based on published studies. The cited study findings — in particular Giannaccare et al. 2019 — reflect the scientific evidence and do not constitute health claims. Food supplements are not a substitute for a balanced diet and healthy lifestyle. For persistent eye complaints, consult an ophthalmologist.